NX
Nexalin Technology, Inc.
NXL · NASDAQ
$4.63 +5.23% (+$0.23)
1M -54.86%
Market Cap $3.74M
P/E Ratio -
Div. Yield -
ROE 278.25%
Bulios Fair Price
$2.44
47.3% downside
Trenutna cena
$4.63
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NXL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
38 /100
Fair P/S 17.23x
P/B 2.46x
P/E N/A
Growth
0 /100
Declining Rev. growth 38.88%
Book val. growth 11.89%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 148.42%
Net margin 4,139.38%
Op. margin 4,202.53%
Quality
1 /100
Poor ROIC 600.62%
ROE 278.25%
ROA 299.21%
Debt
85 /100
Low Debt/Equity 0.00x
Current ratio 1.25x
Int. coverage N/A
Stability
1 /100
Unstable Beta 3.98x
Rev. volatility 91.71%
EPS volatility 108.77%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NXL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mark White
Employees
8
Headquarters
Houston
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report